cbdMD, Inc. ( YCBD) - Key Metrics
YCBD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | $0.56 | -$0.03 | -$0.09 | -$18.30 |
| 2025Q4 | $0.53 | -$0.08 | -$0.03 | -$0.03 |
| 2025Q3 | $0.80 | -$0.15 | -$0.12 | -$0.12 |
| 2025Q2 | $61.01 | -$6.18 | -$2.43 | -$2.63 |
YCBD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | -10.73 |
| 2025Q4 | ? | -3.97 |
| 2025Q3 | ? | -1.44 |
| 2025Q2 | ? | -0.07 |
YCBD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | -9.40% | ? |
| 2026Q1 | -1355.80% | ? |
| 2025Q4 | -2.26% | ? |
| 2025Q3 | -13.68% | ? |
| 2025Q2 | -2.16% | ? |
YCBD
Price: $0.58
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.46 USD
P/E Ratio: 0.30
Exchange: ASE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 457300
Market Capitalization: 7.3 million